High-Risk Plaques: Detection and Management

 

May 3-4, 2008

The Colonnade Hotel

Boston, MA

 

 

Course Directors:

Thomas J. Brady, MD, Massachusetts General Hospital and CIMIT
Ahmed A. Tawakol, MD, Massachusetts General Hospital and CIMIT

Offered by:

Center for Integration of Medicine and Innovative Technology (CIMIT)
Harvard Medical School
Massachusetts General Hospital

 

Saturday, May 3

7:00 - 8:00 AM

Registration

 

8:00

Welcome

Ahmed Tawakol, MD

8:15-11:30

Session 1: Pathophysiology of Atherosclerosis

8:15 – 8:45

Defining the Vulnerable Plaque: New Pathologic Insights

Renu Virmani, MD, FACC

8:45 – 9:30

Inflammation and the Pathogenesis of Atherosclerosis

Peter Libby, MD

9:30-10:00

Break

 

10:00 – 10:30

Inflammatory Triggers of Plaque Rupture

Mohammad Madjid, MD

10:30 – 11:00

Mechanisms of the Acute Coronary Syndromes

Peter Libby, MD

11:00 – 11:30

Discussion

 

11:30 AM to 12:30PM

Lunch

 

12:30 to 5:20 PM

Session 2: Non-Invasive Detection Modalities

12:30 – 1:00

Biomarkers Overview

Paul Ridker, MD

1:00 – 1:30

What has Framingham Taught Us?

Christopher O’Donnell, MD, MPh

1:30 – 2:00

Lipids

Ernst Schaefer, MD

2:00 – 2:30

Discussion

 

2:30-2:45

Break

 

2:45 – 3:10

Imaging Biomarker Overview

Udo Hoffmann, MD

3:10 – 3:35

Carotid Ultrasonography 

Marie Denise Gerhard-Herman, MD

3:35 – 4:00

CT

Thomas Brady, MD

4:00 – 4:25

Positron Emission Tomography 

Ahmed Tawakol, MD

4:25 – 5:00

MRI

Thomas Brady, MD

5:00-5:20

Discussion

 

5:20

Adjourn

 

5:20 – 6:00

Reception

 

 

 

Sunday, May 4

 

 

8:00 AM -12:15 PM

Session 3: Invasive Detection Modalities

8:00 – 8:30

Coronary Arteriography

Pallav Garg, MBBS, FRACP, MSc

8:30 – 9:00

IVUS and Virtual Histology

Geoff Vince, PhD

9:30 – 9:30

Endothelial Shear Stress

Peter Stone, MD

9:30 –10:00

Discussion

 

10:00 –10:15

Break

 

10:15 – 10:45

Intravascular MRI and NIRF

Farouc Jaffer, MD, PhD

10:45 – 11:15

Near-Infrared  Spectroscopy

James Muller, MD

11:15 – 11:45

OCT

Guillermo Tearney, MD, PhD

11:45 –12:15

Discussion

 

12:15 –1:30

Lunch

 

1:30 – 4:00

Session 4: Management of High-Risk Plaques

1:30 – 2:00

Optimal Lipid Management

Jorge Plutzky, MD

2:00 – 2:30

Non-Lipid Pharmacotherapy

Ahmed Tawakol, MD

2:30 – 3:30

Should Drug-Eluting Stents Be Used to Treat VP?

 

 

Yes

Pallav Garg, MBBS, FRACP, MSc

 

No

Aloke Finn, MD

3:30-4:00

Discussion

 

4:00

Adjourn